Egis Pharmaceuticals Private Limited Company
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 20 Nov 2025 | Olivér Várhelyi Commissioner | Opening of new API factory | — |
| 20 Nov 2025 | Olivér Várhelyi Commissioner | Opening of new API factory | SRC |
| 20 Nov 2025 | Laszlo Kristoffy Cabinet member | Opening of new API factory | SRC |
| 26 Mar 2025 | Olivér Várhelyi Commissioner | Visit of EGIS - Exchange on matters related to pharmaceuticals | — |
| 26 Mar 2025 | Olivér Várhelyi Commissioner | Visit of EGIS - Exchange on matters related to pharmaceuticals | SRC |
Mission & Goals
Egis is committed to deliver safe products to patients and customers. Since its establishment more than 110 years ago, Egis has become a leading generic pharmaceutical company in the Central Eastern European region. The composition of our corporate management team demonstrates our activities, which extend to every field of the pharmaceutical value chain: from research and development, through production, to sales and marketing. Egis is a member of the Servier Group, an international pharmaceutical company governed by a non-profit foundation. Our products range from active ingredients, through tablets and injections, to galenic (i.e. liquid and semi-solid) formulations and reach 100 countries in total through our network of subsidiaries and representative offices or partners. Our focus lies on treating diseases of the cardiovascular and central nervous systems; however, we also provide treatment solutions in the fields of diabetology, dermatology and wound care.
EU Legislative Interests
Reform of the EU pharmaceutical legislation; The European Pharmaceutical Strategy; The review of intellectual property incentives; The European Health Union Package; The industrial Strategy; The measures regarding environmental issues, in particular Pharmaceuticals in the Environment; The negotiation of Free-Trade Agreement; The evolution of the digital framework and e-health topics; Union list of critical medicines and the related proposals regarding shortages; revision of the Medical Device Regulation; European Cardiovascular Health Plan;
Communication Activities
- participation in the Critical Medicines Alliance as member - using, supporting, sharing the position papers issued by Medicines for Europe on behalf of their members (please see below an example); https://www.medicinesforeurope.com/wp-content/uploads/2025/12/Medicines-for-Europe-press-release-Safe-Hearts-Plan-171225.pdf
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Medicines for Europe https://www.medicinesforeurope.com/ APIC /CEFIC The European Chemical Industry Council https://apic.cefic.org/ EPI - European Patent Institute https://patentepi.org/en/ ISPE - International Society for Pharmaceutical Engineering https://ispe.org/
Organisation Members
not applicable
Additional Information
Egis' office in charge of EU relations is located within the headquarter of Egis, Egis has no additional rental or other cost regarding the office in charge of EU relations.